Dong-Yao Li

Dong-Yao Li

Auto-generated profile, based on publicly available information

Dong-Yao Li

Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

12 April 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
DLDong‑Yao Li
Dong‑Yao Li
WCWen‑Jie Chen
Wen‑Jie Chen
JSJun Shang
Jun Shang
GCGang Chen
Gang Chen
SLShi‑Kang Li
Shi‑Kang Li
Long non‑coding RNAs (lncRNAs) have been demonstrated to mediate carcinogenesis in various types of cancer. However, the regulatory role of lncRNA LINC00968 in lung adenocarcinoma remains unclear. The microRNA (miRNA) expression in LINC00968‑overexpressing human lung adenocarcinoma A549 cells was detected using miRNA microarray analysis. miR‑9‑3p was selected for further analysis, and its expression was verified in the Gene Expression Omnibus (GEO) database. In addition, the regulatory axis of LINC00968 was validated using The Cancer Genome Atlas (TCGA) database. Results of the GEO database indicated miR‑9‑3p expression in lung adenocarcinoma was significantly higher compared with normal tissues. Functional enrichment analyses of the target genes of miR‑9‑3p indicated protein binding and the AMP‑activated protein kinase pathway were the most enriched Gene Ontology and KEGG terms, respectively. Combining target genes with the correlated genes of LINC00968 and miR‑9‑3p, 120 objective genes were obtained, which were used to construct a protein‑protein interaction (PPI) network. Cyclin A2 (CCNA2) was identified to have a vital role in the PPI network. Significant correlations were detected between LINC00968, miR‑9‑3p and CCNA2 in lung adenocarcinoma. The LINC00968/miR‑9‑3p/CCNA2 regulatory axis provides a new foundation for further evaluating the regulatory mechanisms of LINC00968 in lung adenocarcinoma.